KIF1A

JANUARY 13, 2024

Dylan Verden of KIF1A.ORG summarizes newly published KIF1A-related research and highlights progress in rare disease research and therapeutic development. But studies like these that uncover roles for KIF1A at different times in development can help us get closer to better answers.

DNA 105

DNA Regulations Drug Development Disease 105

Broad Institute

NOVEMBER 21, 2024

Researchers identify source of a brain cancer’s deadly transformation By Corie Lok November 21, 2024 Breadcrumb Home Researchers identify source of a brain cancer’s deadly transformation Slow-growing glioma tumors become more aggressive when their cells shift identities and acquire new genetic mutations.

Research 69

Research Medical Schools DNA Hospitals 69

Alta Sciences

OCTOBER 28, 2024

Top Life Science Resources for Fall 2024 pmjackson Mon, 10/28/2024 - 17:59 There’s a lot of life science content out there, so for your convenience, we’ve curated a selection of expert insights, tips, case studies, and scientific and regulatory information. Image thumbnail_LifeScience_Fall-2024.jpg Read or listen now.

Science 52

Science Clinical Trials Trials FDA 52

Drug Target Review

JULY 18, 2024

Why is detecting cancers via liquid biopsy before they become visible on imaging important for drug development, not just diagnostics? We believe liquid biopsy is very helpful for oncology drug development because the reduction and clearance of circulating DNA occurs quickly before radiographic imaging is available.

Drug Development 59

Drug Development Clinical Trials Drugs Vaccine 59

Alta Sciences

NOVEMBER 1, 2024

42 — Managing The Complexities of Glucagon-Like Peptide-1 Receptor Agonist Drug Development tchichekian Fri, 11/01/2024 - 14:25 Publication The-Altascientist-issue-42-GLP-1-Drug-Development.pdf URL [link] Weight 5 Tags End-to-End Program Preclinical Research Clinical Trials Bioanalysis

Drug Development 40

Drug Development Clinical Trials Drugs Trials 40

Perficient: Drug Development

MAY 28, 2024

On Sunday, May 19th, 2024, 21 individuals consisting of Perficient employees and their family members, participated in the 2024 Michigan Kidney Walk at the Detroit Zoo. More than 80 cents of every dollar raised goes to research, patient services, professional education, public health education, and community services.

Disease 98

Disease Research 98

KIF1A

MAY 31, 2024

Our mission to accelerate research and find a cure for KIF1A Associated Neurological Disorder (KAND) remains our guiding light. Call to Action: Natural History Study Enrollment We urgently need your help to accelerate our research. 6/27 Fundraising Strategy Session : Join us to learn how you can help raise funds for our mission!

Treatment 52

Treatment Hospitals Research Drug Development 52

PPD

NOVEMBER 30, 2023

As we approach the end of 2023, it’s time to reflect on the past 12 months and how advances in drug development shaped the pharma and biotech industries. These shifts are a prelude to further change and progress in the clinical trial landscape in 2024. Five Predictions for the Drug Development Industry in 2024 1.

Clinical Trials 98

Clinical Trials Trials Clinical Research Drug Development 98

LifeSciVC

JANUARY 16, 2024

Whether trial design, execution, or otherwise, drug development even where there is precedent is a challenging road and should not be taken for granted. Let’s agree to make 2024 the year we take action and voice concerns for legislation that encumbers the ability for biotech to deliver on its promise to patients and caregivers.

Small Molecule 139

Small Molecule Trials Therapies Disease 139

Fierce BioTech

MARCH 12, 2024

Listing Image PPD-TF-logo.png Listing Introduction Get the latest FSP trends, strategies, and projections for biopharma and biotech companies as Lori Boyce, Vice President, PPD FSP Solutions, and Mike Lydon, Director, PPD FSP Solutions, share findings from The 2024 FSP Trends Report. On Demand Start Date Thu, 04/11/2024 - 12:00

Clinical Research 52

Clinical Research Drug Development Trials Research 52

Alta Sciences

AUGUST 29, 2024

Engaging at the outset with a fully integrated and experienced drug development partner can ensure safety, with timely data sharing at every step of the drug development plan, and facilitate agile, flexible decision-making and planning. WHAT IS THE ALTASCIENTIST ? View the full library of The Altascientist publications.

Drug Development 52

Drug Development Small Molecule Clinical Trials Drugs 52

Fierce BioTech

APRIL 3, 2024

Mini-Organs, Major Breakthroughs: How Hub Organoids Are Accelerating Oncology Drug Development dwunderlin Wed, 04/03/2024 - 17:28 Tue, 05/14/2024 - 09:30 Resource Type Webinar Dr. Sylvia F. On Demand Start Date Tue, 05/14/2024 - 10:30 Click here to login. Click here to login. Listing Image Hub_ListingLogo_250x190.png

Drug Development 52

Drug Development Drugs Therapies Treatment 52

Perficient: Drug Development

AUGUST 19, 2024

We’re thrilled to announce that Perficient has been recognized as a 2024 Top Workplace by the Atlanta Journal-Constitution ! Every year, an anonymous survey conducted by a renowned research firm evaluates key aspects of the workplace, including organizational leadership, company values, career opportunities, work-life balance, and more.

Research 105

Research 105

Alta Sciences

AUGUST 12, 2024

Metabolic Drug Development: A to Z Solutions blussier Mon, 08/12/2024 - 18:07 HTML In the complex and dynamic field of metabolic drug development, partnering with an accomplished contract research organization is essential.

Drug Development 40

Drug Development Clinical Trials Pharmacokinetics Drugs 40

Perficient: Drug Development

JANUARY 9, 2024

Medical device industry trends for 2024. Let’s look at what is poised to impact the medical device industry in 2024. Let’s look at what is poised to impact the medical device industry in 2024. The medical device industry is in a constant state of evolution. population will be 65 and older by the year 2060.

Production 110

Production Clinical Trials Marketing Trials 110

Alta Sciences

MAY 28, 2024

Altasciences Receives 2024 CRO Leadership Award for Capabilities aasimakopoulos Wed, 05/29/2024 - 17:54 Laval, Québec, May 29, 2024 – Altasciences announced today that it has been recognized for excellence in contract research with a 2024 CRO Leadership Award for Capabilities.

Clinical Pharmacology 40

Clinical Pharmacology Drug Development Science Clinical Research 40

Alta Sciences

MAY 14, 2024

Selecting the Ideal Dosage Form for Your Drug Development Program blussier Wed, 05/15/2024 - 01:08 HTML Choose Wisely. With decades of experience developing and manufacturing almost every dosage form on the market, our experts can guide you in selecting the optimal one for your drug development program.

Drug Development 40

Drug Development Clinical Trials Drugs Pharmaceuticals 40

Fierce BioTech

NOVEMBER 22, 2024

AI in Pharma: Benefits, Risks and the Road Ahead AI is revolutionizing the drug development process, streamlining and accelerating every stage, from research to approval and marketing. This whitepaper explores the benefits and risks of AI in the pharmaceutical industry and examines its future.

Drug Development 52

Drug Development Pharmaceuticals Marketing Research 52

Alta Sciences

APRIL 5, 2024

The mini documentary explores transformation in the slow-to-change drug development industry. Leaders from Altasciences dive into the obstacles and inefficiencies of the traditional outsourcing relationship between CROs and drug sponsors, and how Altasciences has broken from tradition to address these challenges.

Drug Development 52

Drug Development Pharma Companies Marketing Drugs 52

DrugBank

AUGUST 9, 2024

Investment Trends in Pharmaceutical Research and Development Investing in the pharmaceutical sector presents a unique set of challenges and opportunities; let’s examine them in more detail.    The average cost of bringing a new drug to market is about $2.6 trillion dollars, and it is forecasted to exceed 1.4

Pharmaceuticals 77

Pharmaceuticals Research Pharmaceutical Companies Clinical Trials 77

Perficient: Drug Development

APRIL 25, 2024

SUGCON (Sitecore User Group Conference) Europe 2024 was the second SUGCON I’ve attended, with the first just being six months ago in Minneapolis. I’ve developed real friendships with folks from literally every corner of the world and it’s only once or twice a year we get the whole “Sitecore Family” together.

Production 109

Production Engineering Marketing Research 109

FDA Law Blog: Drug Discovery

MAY 19, 2024

By Sarah Wicks — On May 21, 2024, the EveryLife Foundation for Rare Diseases (ELF) will host a Scientific Workshop at the National Press Club in Washington, D.C. aimed at identifying and characterizing the challenges in developing therapies for ultra-rare diseases and conditions that affect exceedingly small populations.

Disease 59

Disease Therapies Drug Development FDA 59

PPD

MARCH 28, 2024

Through the first few months of 2024, the economic landscape is showing signs of returning to a semblance of normalcy, mirroring the pre-COVID era. According to Jeffries Equity Research, funding totals exceeded $15 billion in January and February, marking the best monthly tallies in over a year.

Trials 52

Trials Clinical Trials Drug Development Clinical Research 52

Perficient: Drug Development

OCTOBER 25, 2024

Forrester’s 2024 report recognizes 42 notable providers– and we’re proud to announce that Perficient is among them. Download the Forrester report, The Application Modernization And Multicloud Managed Services Landscape, Q4 2024 , to learn more (link to report available to Forrester subscribers and for purchase).

Production 64

Production Marketing Science Research 64

Perficient: Drug Development

JULY 1, 2024

We are thrilled to announce that Perficient has been recognized as a 2024 Top Workplace by the St. The anonymous survey, conducted by a renowned research firm, evaluates several key aspects of the workplace, including organizational leadership, company values, career opportunities, work-life balance, and more. Louis Post-Dispatch !

Research 64

Research 64

Vial

MAY 20, 2024

Distinguishing the Roles of Preclinical vs. Clinical CROs in Clinical Research Randomized clinical trials are the gold-standard of evidence-based medicine, representing the culmination of the long, arduous drug development pipeline. What is a Pre-Clinical CRO? The global preclinical CRO market was estimated to be valued at US$5.7

Clinical Research 52

Clinical Research Clinical Trials Research Trials 52

Alta Sciences

MARCH 27, 2024

Up Close and Personal With Eryn Corriveau, MSc, Senior Director, Drug Development and Regulatory Strategy nbartlett Wed, 03/27/2024 - 20:21 Here at Altasciences, Eryn is responsible for guiding regulatory strategies , conducting gap analyses, and leading interactions with regulatory agencies dur ing early drug development.

Drug Development 52

Drug Development Medical Schools Pharma Companies Drugs 52

Perficient: Drug Development

FEBRUARY 1, 2024

The conference will take place on February 11-14, 2024, in Orlando, Florida. The SCOPE (Summit for Clinical Ops Executives) conference is a premier event in the field of clinical operations, providing a comprehensive platform for professionals to explore the latest trends and innovations in clinical research. Still not registered?

Science 59

Science Clinical Research Clinical Trials Trials 59

Agency IQ

AUGUST 2, 2024

What We Expect the FDA to do in August and September 2024 In this ongoing feature, AgencyIQ looks at public data to determine what the FDA is likely to do in the months ahead, including key deadlines, meetings, events, planned regulations, comment periods and more.

FDA 40

FDA Science Regulations Biosimilars 40

Agency IQ

MAY 3, 2024

What We Expect the FDA to do in May and June 2024 In this ongoing feature, AgencyIQ looks at public data to determine what the FDA is likely to do in the months ahead, including key deadlines, meetings, events, planned regulations, comment periods and more.

FDA 40

FDA Science Regulations Clinical Trials 40

Perficient: Drug Development

MARCH 19, 2024

Our experts are closely monitoring nine healthcare trends that are shaping industry leaders’ strategies in 2024. Recommended Approach : Experience is key, especially as a growing number of consumers research care options within a competitive marketplace.

Pharmacy 52

Pharmacy Nurses Marketing Engineering 52

Perficient: Drug Development

MARCH 5, 2024

As the new year has begun, the Digital Marketing team at Perficient has identified a number of areas where they expect a continued focus throughout 2024 within their areas of expertise. In 2024, content that is sincere and authentic will stand out.

Marketing 52

Marketing Engineering Production Research 52

Agency IQ

JULY 22, 2024

Halfway there: Novel drug approvals and their supportive clinical trials so far in 2024 In the first half of 2024, the FDA’s Center for Drug Evaluation and Research (CDER) approved 21 novel drug products. Halfway through 2024: how are novel drug approvals shaping up? population.

Clinical Trials 52

Clinical Trials Trials Science FDA 52

Agency IQ

JULY 8, 2024

What we expect European regulators to do in July 2024 In this recurring feature, AgencyIQ, through public data and previous analysis, determines what European medicine and device regulators will likely do in the month ahead, including key deadlines, meetings, events, planned regulations, comment periods, and more. and national regulators.

Regulations 40

Regulations Pharmaceuticals Production Vaccine 40

Perficient: Drug Development

JANUARY 23, 2024

A few weeks back, I wrote about key trends that would impact the medical device world in 2024. This time around, I’m going to be counting down some 2024 resolutions for medical device marketers. Caregivers have a tough job, and they are very influential when it comes to product research and purchasing.

Marketing 52

Marketing Testimonials Production Science 52

Alta Sciences

NOVEMBER 6, 2024

Going Above and Beyond to Exceed Your Expectations blussier Wed, 11/06/2024 - 19:14 HTML In this new video , our clinical and manufacturing experts share how their teams collaborate and tailor solutions to meet your unique needs. Looking for a more seamless drug development and manufacturing experience? Start watching!

Clinical Trials 52

Clinical Trials Trials Drug Development Pharmaceuticals 52

Alta Sciences

NOVEMBER 13, 2024

Altasciences’ Commitment to Supporting Pharma and Biotech With Comprehensive Bioanalytical Services pmjackson Wed, 11/13/2024 - 14:50 Greater Montréal, Québec, 11/13, 2024 — Altasciences , a trusted drug development research partner for over 30 years, continues its commitment to providing world-class bioanalytical services.

Clinical Pharmacology 40

Clinical Pharmacology Laboratories Drug Development Pharmaceuticals 40